STOCK TITAN

[Form 4] LeMaitre Vascular, Inc. Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4

LeMaitre Vascular, Inc. (LMAT) insider transaction by Chairman and CEO George W. LeMaitre. The Form 4 reports transactions dated 09/05/2025 showing multiple non-derivative dispositions and one indirect acquisition into an irrevocable life insurance trust. Aggregate reported sales: 42,500 shares disposed (three entries: 10,600; 10,600; 21,300) at $0 reported price under code "G," and a separate entry showing 21,300 shares acquired indirectly into the "LEMAITRE IRREVOCABLE LIFE INSURANCE TRUST OF 2025." Following the reported sales, direct beneficial ownership counts are reduced to 1,663,303; 1,684,603; and 1,695,203 on respective lines, while the trust holds 21,300 shares indirectly. The filer disclaims beneficial ownership of the trust shares except to the extent of any pecuniary interest.

Operazione interna di LeMaitre Vascular, Inc. (LMAT) effettuata dal Presidente e CEO George W. LeMaitre. Il Modulo 4 riporta operazioni datate 05/09/2025 che mostrano più cessioni non derivati e un unico acquisto indiretto in un trust assicurativo irrevocabile. Vendite complessive segnalate: 42.500 azioni cedute (tre voci: 10.600; 10.600; 21.300) a prezzo indicato di $0 con codice "G", e una voce separata che indica l’acquisizione indiretta di 21.300 azioni nel "LEMAITRE IRREVOCABLE LIFE INSURANCE TRUST OF 2025." Dopo le vendite dichiarate, le detenzioni dirette di proprietà beneficiaria risultano ridotte rispettivamente a 1.663.303; 1.684.603; e 1.695.203 azioni, mentre il trust detiene indirettamente 21.300 azioni. Il dichiarante esclude la titolarità beneficiaria delle azioni del trust salvo per l’eventuale interesse pecuniario.

Transacción interna de LeMaitre Vascular, Inc. (LMAT) realizada por el presidente y CEO George W. LeMaitre. El Formulario 4 informa operaciones con fecha 05/09/2025 que muestran múltiples enajenaciones no derivadas y una adquisición indirecta en un fideicomiso de seguro de vida irrevocable. Ventas agregadas reportadas: 42.500 acciones vendidas (tres registros: 10.600; 10.600; 21.300) a precio declarado de $0 bajo el código "G", y una entrada separada que indica la adquisición indirecta de 21.300 acciones en el "LEMAITRE IRREVOCABLE LIFE INSURANCE TRUST OF 2025." Tras las ventas informadas, la propiedad beneficiaria directa queda reducida a 1.663.303; 1.684.603; y 1.695.203 en las líneas respectivas, mientras que el fideicomiso posee 21.300 acciones de forma indirecta. El declarante renuncia a la propiedad beneficiaria de las acciones del fideicomiso salvo en la medida de cualquier interés pecuniario.

LeMaitre Vascular, Inc.(LMAT)의 내부거래: 회장 겸 CEO 조지 W. 르메트르(George W. LeMaitre). Form 4는 2025-09-05일자로 여러 비파생 처분과 하나의 간접 취득(무효불가 생명보험 신탁)을 보고하고 있습니다. 보고된 총 매도는 42,500주(세 항목: 10,600; 10,600; 21,300)이며, 코드 "G"로 보고된 가격은 $0입니다. 별도 항목으로 "LEMAITRE IRREVOCABLE LIFE INSURANCE TRUST OF 2025"로 간접 취득된 21,300주가 기재되어 있습니다. 보고된 매도 후 직접적 수혜권 보유는 각 항목별로 1,663,303주; 1,684,603주; 1,695,203주로 감소했으며, 신탁은 21,300주를 간접 보유하고 있습니다. 제출인은 신탁 주식에 대한 수혜적 소유를 금전적 이익의 범위 내에서만 인정합니다.

Transaction d'initié chez LeMaitre Vascular, Inc. (LMAT) par le président et CEO George W. LeMaitre. Le formulaire 4 signale des opérations datées du 05/09/2025 montrant plusieurs cessions non dérivées et une acquisition indirecte au sein d'une fiducie d'assurance-vie irrévocable. Ventes totales déclarées : 42 500 actions cédées (trois lignes : 10 600; 10 600; 21 300) au prix déclaré de 0 $ sous le code « G », et une entrée distincte indiquant l'acquisition indirecte de 21 300 actions dans le « LEMAITRE IRREVOCABLE LIFE INSURANCE TRUST OF 2025 ». Après les ventes déclarées, la détention directe bénéficiaire est réduite respectivement à 1 663 303 ; 1 684 603 ; et 1 695 203 actions, tandis que la fiducie détient indirectement 21 300 actions. Le déclarant décline la propriété bénéficiaire des actions détenues par la fiducie, sauf dans la mesure d'un intérêt pécuniaire éventuel.

Insider-Transaktion von LeMaitre Vascular, Inc. (LMAT) durch Vorsitzenden und CEO George W. LeMaitre. Das Formular 4 meldet Transaktionen vom 05.09.2025, die mehrere nicht-derivative Veräußerungen und eine indirekte Erwerbung in einen unwiderruflichen Lebensversicherungs-Trust zeigen. Gesamtgemeldete Verkäufe: 42.500 veräußerte Aktien (drei Einträge: 10.600; 10.600; 21.300) zu einem gemeldeten Preis von $0 unter dem Code „G“, und ein separater Eintrag, der den indirekten Erwerb von 21.300 Aktien in den "LEMAITRE IRREVOCABLE LIFE INSURANCE TRUST OF 2025" ausweist. Nach den gemeldeten Verkäufen verringern sich die direkten wirtschaftlichen Eigentumsanteile in den jeweiligen Zeilen auf 1.663.303; 1.684.603; bzw. 1.695.203, während der Trust indirekt 21.300 Aktien hält. Der Melder bestreitet die wirtschaftliche Eigentümerschaft der Trust-Aktien, außer insoweit ein pecuniäres Interesse besteht.

Positive
  • Timely disclosure: The Form 4 is signed and discloses the transactions, supporting regulatory transparency.
  • Use of irrevocable trust: 21,300 shares are placed in the LEMAITRE IRREVOCABLE LIFE INSURANCE TRUST OF 2025 with an ownership disclaimer, indicating estate-planning structuring rather than a market sale.
Negative
  • Significant insider share movement: The reporting person shows total disposals of 42,500 shares on 09/05/2025, which reduces direct holdings and may be notable given the holder's executive role.
  • Price reported as $0 for disposals: All transactions list a $0 price with code "G," which requires investor attention to understand transfer nature rather than standard open-market sales.

Insights

TL;DR: Multiple share disposals by the CEO/Chairman with an indirect trust acquisition; disclosure is routine but notable for size.

The filing shows the Reporting Person acting in multiple capacities (Chairman and CEO) and reporting significant non-derivative dispositions on a single date totaling 42,500 shares via code "G," which typically indicates a gift to a trust or similar transfer under Section 16 reporting rules. There is an explicit indirect acquisition of 21,300 shares into an irrevocable life insurance trust, and the reporting person disclaims beneficial ownership of trust-held shares. For governance reviewers, the key points are the concentration of insider holdings, the use of an irrevocable trust for estate planning, and clean disclosure compliance. The filing contains no derivative transactions or option exercises.

TL;DR: Accurate, timely Form 4 reporting of insider activity; transactions appear to be transfers rather than market sales.

The Form 4 lists transaction code "G" across all reported entries dated 09/05/2025, and a price of $0 is shown, consistent with non-sale transfers such as gifts or transfers to a trust. The reporter checked boxes indicating both director and officer status and filed as a single reporting person. The explanatory note clarifies the trust beneficiary relationship and disclaimer of beneficial ownership. From a compliance perspective the form is complete: it lists pre- and post-transaction ownership counts and includes a signature and filing date. No material omissions are evident within the provided text.

Operazione interna di LeMaitre Vascular, Inc. (LMAT) effettuata dal Presidente e CEO George W. LeMaitre. Il Modulo 4 riporta operazioni datate 05/09/2025 che mostrano più cessioni non derivati e un unico acquisto indiretto in un trust assicurativo irrevocabile. Vendite complessive segnalate: 42.500 azioni cedute (tre voci: 10.600; 10.600; 21.300) a prezzo indicato di $0 con codice "G", e una voce separata che indica l’acquisizione indiretta di 21.300 azioni nel "LEMAITRE IRREVOCABLE LIFE INSURANCE TRUST OF 2025." Dopo le vendite dichiarate, le detenzioni dirette di proprietà beneficiaria risultano ridotte rispettivamente a 1.663.303; 1.684.603; e 1.695.203 azioni, mentre il trust detiene indirettamente 21.300 azioni. Il dichiarante esclude la titolarità beneficiaria delle azioni del trust salvo per l’eventuale interesse pecuniario.

Transacción interna de LeMaitre Vascular, Inc. (LMAT) realizada por el presidente y CEO George W. LeMaitre. El Formulario 4 informa operaciones con fecha 05/09/2025 que muestran múltiples enajenaciones no derivadas y una adquisición indirecta en un fideicomiso de seguro de vida irrevocable. Ventas agregadas reportadas: 42.500 acciones vendidas (tres registros: 10.600; 10.600; 21.300) a precio declarado de $0 bajo el código "G", y una entrada separada que indica la adquisición indirecta de 21.300 acciones en el "LEMAITRE IRREVOCABLE LIFE INSURANCE TRUST OF 2025." Tras las ventas informadas, la propiedad beneficiaria directa queda reducida a 1.663.303; 1.684.603; y 1.695.203 en las líneas respectivas, mientras que el fideicomiso posee 21.300 acciones de forma indirecta. El declarante renuncia a la propiedad beneficiaria de las acciones del fideicomiso salvo en la medida de cualquier interés pecuniario.

LeMaitre Vascular, Inc.(LMAT)의 내부거래: 회장 겸 CEO 조지 W. 르메트르(George W. LeMaitre). Form 4는 2025-09-05일자로 여러 비파생 처분과 하나의 간접 취득(무효불가 생명보험 신탁)을 보고하고 있습니다. 보고된 총 매도는 42,500주(세 항목: 10,600; 10,600; 21,300)이며, 코드 "G"로 보고된 가격은 $0입니다. 별도 항목으로 "LEMAITRE IRREVOCABLE LIFE INSURANCE TRUST OF 2025"로 간접 취득된 21,300주가 기재되어 있습니다. 보고된 매도 후 직접적 수혜권 보유는 각 항목별로 1,663,303주; 1,684,603주; 1,695,203주로 감소했으며, 신탁은 21,300주를 간접 보유하고 있습니다. 제출인은 신탁 주식에 대한 수혜적 소유를 금전적 이익의 범위 내에서만 인정합니다.

Transaction d'initié chez LeMaitre Vascular, Inc. (LMAT) par le président et CEO George W. LeMaitre. Le formulaire 4 signale des opérations datées du 05/09/2025 montrant plusieurs cessions non dérivées et une acquisition indirecte au sein d'une fiducie d'assurance-vie irrévocable. Ventes totales déclarées : 42 500 actions cédées (trois lignes : 10 600; 10 600; 21 300) au prix déclaré de 0 $ sous le code « G », et une entrée distincte indiquant l'acquisition indirecte de 21 300 actions dans le « LEMAITRE IRREVOCABLE LIFE INSURANCE TRUST OF 2025 ». Après les ventes déclarées, la détention directe bénéficiaire est réduite respectivement à 1 663 303 ; 1 684 603 ; et 1 695 203 actions, tandis que la fiducie détient indirectement 21 300 actions. Le déclarant décline la propriété bénéficiaire des actions détenues par la fiducie, sauf dans la mesure d'un intérêt pécuniaire éventuel.

Insider-Transaktion von LeMaitre Vascular, Inc. (LMAT) durch Vorsitzenden und CEO George W. LeMaitre. Das Formular 4 meldet Transaktionen vom 05.09.2025, die mehrere nicht-derivative Veräußerungen und eine indirekte Erwerbung in einen unwiderruflichen Lebensversicherungs-Trust zeigen. Gesamtgemeldete Verkäufe: 42.500 veräußerte Aktien (drei Einträge: 10.600; 10.600; 21.300) zu einem gemeldeten Preis von $0 unter dem Code „G“, und ein separater Eintrag, der den indirekten Erwerb von 21.300 Aktien in den "LEMAITRE IRREVOCABLE LIFE INSURANCE TRUST OF 2025" ausweist. Nach den gemeldeten Verkäufen verringern sich die direkten wirtschaftlichen Eigentumsanteile in den jeweiligen Zeilen auf 1.663.303; 1.684.603; bzw. 1.695.203, während der Trust indirekt 21.300 Aktien hält. Der Melder bestreitet die wirtschaftliche Eigentümerschaft der Trust-Aktien, außer insoweit ein pecuniäres Interesse besteht.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
LeMaitre George W

(Last) (First) (Middle)
C/O LEMAITRE VASCULAR, INC.
63 SECOND AVENUE

(Street)
BURLINGTON MA 01803

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
LEMAITRE VASCULAR INC [ LMAT ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
X Officer (give title below) Other (specify below)
Chairman and CEO
3. Date of Earliest Transaction (Month/Day/Year)
09/05/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 09/05/2025 G 10,600 D $0 1,695,203 D
Common Stock 09/05/2025 G 10,600 D $0 1,684,603 D
Common Stock 09/05/2025 G 21,300 D $0 1,663,303 D
Common Stock 09/05/2025 A 21,300 A $0 21,300 I LEMAITRE IRREVOCABLE LIFE INSURANCE TRUST OF 2025(1)
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. These shares are held by an irrevocable trust for the benefit of Reporting Person's child(ren). The Reporting Person disclaims ownership of such securities except to the extent of his pecuniary interest therein, if any, and the reporting herein of such securities shall not be construed as an admission of beneficial ownership thereof for the purposes of Section 16 or for any other purpose.
/s/ Nathan Ulrich 09/09/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider filed this Form 4 for LMAT?

George W. LeMaitre, Chairman and CEO, filed the Form 4 reporting his transactions.

What transactions are reported on the 09/05/2025 Form 4 for LMAT?

Multiple non-derivative transactions dated 09/05/2025: three dispositions (10,600; 10,600; 21,300 shares) and one indirect acquisition of 21,300 shares into an irrevocable life insurance trust.

What does transaction code "G" mean on this Form 4?

Code "G" is used in the filing and generally indicates a transfer to a trust or a gift; here the entries show $0 price consistent with non-sale transfers.

How many shares does the trust hold according to the filing?

21,300 shares are reported as held indirectly by the LEMAITRE IRREVOCABLE LIFE INSURANCE TRUST OF 2025.

Did the reporting person disclaim beneficial ownership of trust shares?

Yes. The explanatory note states the reporting person disclaims ownership of the trust securities except to the extent of any pecuniary interest.
Lemaitre Vasculr

NASDAQ:LMAT

LMAT Rankings

LMAT Latest News

LMAT Latest SEC Filings

LMAT Stock Data

2.09B
20.87M
7.8%
95.11%
5.96%
Medical Instruments & Supplies
Surgical & Medical Instruments & Apparatus
Link
United States
BURLINGTON